Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
HIV/AIDS Vaccines
Researchers' data advance HIV/AIDS vaccines research
September 14th, 2005
Data on HIV/AIDS vaccines are outlined in reports from the United States and United Kingdom. Study 1: Researchers describe the cross-reactivity of anti-HIV-1 T cell immune responses among the major HIV-1 clades in HIV-1-positive individuals from four continents in a recent issue of the Journal of Infectious Diseases. "The genetic diversity of human immunodeficiency virus type 1 (HIV-1) raises the question of whether vaccines that include a component to elicit antiviral T cell immunity based on a single viral genetic clade could provide cellular immune protection against divergent HIV-1 clades. Therefore, we quantified the cross-clade...
Source: Vaccine Weekly (2005-09-14)
|
